Controller therapy attenuates asthma exacerbations associated with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children.

Ann Allergy Asthma Immunol · 2023 · PMC10263224 · PMID 37321447

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp=0.06so close (0.05 < p ≤ 0.1)

Combination therapy resulted in significant decreases in ED visits (RR=0.38, p<0.05), OCS fills (RR=0.72, p<0.05), SABA fills (RR=0.48, p<0.05), and borderline significant reduced hospitalizations (RR=0.47, p=0.06).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.